Abstract
Purpose
To report the visual and surgical outcomes of mitomycin-C (MMC) augmented non-penetrating deep sclerectomy (NPDS) and phacoemulsification in patients with severe and end-stage glaucoma.
Materials and methods
A retrospective analysis of 349 eyes of 320 patients who underwent combined NPDS with phacoemulsification surgery between January 2018 to December 2020 were included.
Main outcome measures
Best corrected visual acuity (BCVA), status of central visual fields, intra ocular pressure (IOP), number of antiglaucoma medications (AGM) were compared from baseline to post-operative visits, surgical complications and interventions were noted.
Results
Mean logMAR BCVA improved significantly from baseline of 0.54 ± 0.42 to 0.30 ± 0.37 & 0.29 ± 0.40 at 6(p < 0.001) & 12 months (p < 0.001) postoperatively. HFA 10-2 analysis revealed no significant post operative change in mean deviation from baseline at 6 & 12 months (p = 0.072, p = 0.143) respectively. Significant post-operative reduction in mean (SD) IOP was noted from baseline of 17.54(5.43) mmHg to 15.10(5.34) & 16.23(6.87) mmHg at 6 months(p < 0.001) and one year(p < 0.001) respectively. Similarly, the need for AGM also reduced significantly from 2.95(1.01) to 1.93(0.98) & 2.01 (0.99) at 6 (p < 0.001)& 12 months(p < 0.001) postoperatively. Cumulative surgical success was 95% and 93% at 6 months and 1 year respectively. Complications were seen in 17.8% patients and most were related to poor IOP control (8.3%). Two (0.6%) patients underwent tube surgery and 3 (0.9%) had undergone diode laser cyclophotocoagulation for refractory high IOP.
Conclusion
MMC augmented NPDS combined with phacoemulsification surgery is a safe and a viable option in eyes with advanced glaucoma maintaining stable visual acuity and visual fields postoperatively.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
References
Kastner A, King AJ. Advanced glaucoma at diagnosis: current perspectives. Eye (Lond). 2020;34:116–28.
Mokhles P, Schouten JSAG, Beckers HJM, Azuara-Blanco A, Tuulonen A, Webers CAB. A systematic review of end-of-life visual impairment in open-angle glaucoma: an epidemiological autopsy. J Glaucoma. 2016;25:623–8.
Lee JM, Caprioli J, Nouri-Mahdavi K, Afifi AA, Morales E, Ramanathan M, et al. Baseline prognostic factors predict rapid visual field deterioration in glaucoma. Invest Ophthalmol Vis Sci. 2014;554:2228–36.
Anon. The Advanced Glaucoma Intervention Study (AGIS): 7.The relationship between control of intraocular pressure and visual field deterioration. AGIS Investig Am J Ophthalmol. 2000;1304:429–40.
King AJ, Hudson J, Fernie G, Kernohan A, Azuara-Blanco A, Burr J, et al. Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS). BMJ. 2021;373:n1014.
DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120:297–300.
Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed II, et al. Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up. Ophthalmology. 2022;129:1344–56.
Leleu I, Penaud B, Blumen-Ohana E, Rodallec T, Adam R, Laplace O, et al. Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results. Graefes Arch Clin Exp Ophthalmol. 2018;256:1489–98.
Panigrahi A, Kumar A, Gupta S, Grover DS, Gupta V Outcomes of gonioscopy-assisted transluminal trabeculotomy in advanced pigmentary glaucoma. Br J Ophthalmol. 2024: bjo-2024-325749.
Costa VP, Smith M, Spaeth GL, Gandham S, Markovitz B. Loss of visual acuity after trabeculectomy. Ophthalmology. 1993;100:599–612.
Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology. 2013;120:2532–9.
El Sayyad F, Helal M, El-Kholify H, Khalil M, El-Maghraby A. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology. 2000;107:1671–4.
Chiselita D. Non-penetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery. Eye (Lond). 2001;15:197–201.
Dwivedi R, Somerville T, Cheeseman R, Rogers C, Batterbury M, Choudhary A. Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes. Graefes Arch Clin Exp Ophthalmol. 2021;259:1965–74.
Shaarawy T, Mansouri K, Schnyder C, Ravinet E, Achache F, Mermoud A. Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg. 2004;30:1225–31.
Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma. 2002;11:287–93.
Ates H, Andac K, Uretmen O. Non-penetrating deep sclerectomy and collagen implant surgery in glaucoma patients with advanced field loss. Int Ophthalmol. 1999;23:123–8.
Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24–30.
Law SK, Nguyen AM, Coleman AL, Caprioli J. Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol. 2007;125:1044–50.
Bengtsson B, Heijl A. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Am J Ophthalmol. 2000;130:689.
Oh LJ, Wong E, Lam J, Clement CI. Comparison of bleb morphology between trabeculectomy and deep sclerectomy using a clinical grading scale and anterior segment optical coherence tomography. Clin Exp Ophthalmol. 2017;45:701–7.
Richardson-May J, Alnuaimi R, Elbably A, Walker L, Thulasidharan S, Dacombe R, et al. Our experience of deep sclerectomy at a tertiary center in the United Kingdom Over 14 Years. Cureus. 2023;15:e43366.
Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye (Lond). 2005;19:442–50.
Cheng J-W, Cai J-P, Li Y, Wei R-L. Intraoperative mitomycin C for nonpenetrating glaucoma surgery: a systematic review and meta-analysis. J Glaucoma. 2011;20:322–6.
Mercieca K, Shevade B, Anand N. Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. Eye (Lond). 2015;29:1495–503.
Di Matteo F, Bettin P, Fiori M, Ciampi C, Rabiolo A, Bandello F. Nd:Yag laser goniopuncture for deep sclerectomy: efficacy and outcomes. Graefes Arch Clin Exp Ophthalmol. 2016;254:535–9.
Koukkoulli A, Musa F, Anand N. Long-term outcomes of needle revision of failing deep sclerectomy blebs. Graefes Arch Clin Exp Ophthalmol. 2015;253:99–106.
Denis D, Pommier S, Coste R, Fogliarini C, Benso C, Cornand E. [Deep sclerectomy in congenital glaucoma: results of a study lasting more than 3 years]. J Fr Ophtalmol. 2008;31:173–9.
Elhofi A, Helaly HA. Non-Penetrating Deep Sclerectomy versus Trabeculectomy in Primary Congenital Glaucoma. Clin Ophthalmol. 2020;14:1277–85.
Rabiolo A, Leadbetter D, Alaghband P, Anand N. Primary deep sclerectomy in open-angle glaucoma: long-term outcomes and risk factors for failure. Ophthalmol Glaucoma. 2021;4:149–61.
Rulli E, Biagioli E, Riva I, Gambirasio G, De Simone I, Floriani I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131:1573–82.
Yuen NSY, Chan OCC, Hui SP, Ching RHY. Combined phacoemulsification and nonpenetrating deep sclerectomy in the treatment of chronic angle-closure glaucoma with cataract. Eur J Ophthalmol. 2007;17:208–15.
Xiao J-Y, Liang A-Y, Wang Y-L, Cheng G-W, Zhang M-F. Efficacy and safety of non-penetrating glaucoma surgery with phacoemulsification versus non-penetrating glaucoma surgery: a Meta-analysis. Int J Ophthalmol. 2021;14:1970–8.
Kleinmann G, Katz H, Pollack A, Schechtman E, Rachmiel R, Zalish M. Comparison of trabeculectomy with mitomycin C with or without phacoemulsification and lens implantation. Ophthalmic Surg Lasers. 2002;33:102–8.
Lochhead J, Casson RJ, Salmon JF. Long term effect on intraocular pressure of phacotrabeculectomy compared to trabeculectomy. Br J Ophthalmol. 2003;87:850–2.
Gianoli F, Schnyder CC, Bovey E, Mermoud A. Combined surgery for cataract and glaucoma: phacoemulsification and deep sclerectomy compared with phacoemulsification and trabeculectomy. J Cataract Refract Surg. 1999;25:340–6.
Stead RE, King AJ. Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma. Br J Ophthalmol. 2011;95:960–5.
Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond). 2002;16:297–303.
Mendrinos E, Mermoud A, Shaarawy T. Nonpenetrating glaucoma surgery. Surv Ophthalmol. 2008;53:592–630.
Mercieca K, Steeples L, Anand N. Medscape. Deep sclerectomy for uveitic glaucoma: long-term outcomes. Eye (Lond). 2017;31:1008–19.
Suominen S, Harju M, Ihanamäki T, Vesti E. The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results. Acta Ophthalmol. 2010;88:27–32.
Elhofi A, Helaly HA. Outcome of primary nonpenetrating deep sclerectomy in patients with steroid-induced glaucoma. J Ophthalmol. 2018;2018:9215650.
Author information
Authors and Affiliations
Contributions
Concepts: RS, VAS. Design: RS, VAS. Definition of intellectual content: RS, TS, MR, VAS. Literature search: RS, TS, MR, JK, VAS. Clinical studies: RS, JK, KBS, VAS. Experimental studies: RS, TS. Data acquisition: TS, MR, JK. Data analysis: KBS. Statistical analysis: KBS. Manuscript preparation: RS, TS, MR, JK, VAS. Manuscript editing: RS, KBS, VAS. Manuscript review: RS, KBS, VAS. Guarantor: RS, VAS.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sharmila, R., Sruthi, T., Rao, M. et al. Visual and surgical outcomes of MMC augmented combined non-penetrating deep sclerectomy and phacoemulsification in eyes with severe and end stage glaucoma. Eye 39, 1571–1577 (2025). https://doi.org/10.1038/s41433-025-03719-z
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-025-03719-z


